X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6517) 6517
Publication (538) 538
Book Review (140) 140
Book Chapter (56) 56
Conference Proceeding (24) 24
Dissertation (15) 15
Magazine Article (7) 7
Newsletter (7) 7
Data Set (2) 2
Web Resource (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4068) 4068
female (2159) 2159
electrocardiography (1920) 1920
male (1878) 1878
index medicus (1867) 1867
cardiac & cardiovascular systems (1755) 1755
torsade-de-pointes (1719) 1719
torsades de pointes - chemically induced (1442) 1442
animals (1402) 1402
torsades-de-pointes (1396) 1396
pharmacology & pharmacy (1311) 1311
torsades de pointes (1219) 1219
torsade de pointes (1200) 1200
arrhythmia (1057) 1057
middle aged (1043) 1043
long qt syndrome (1011) 1011
adult (962) 962
long qt syndrome - chemically induced (954) 954
risk factors (886) 886
aged (860) 860
torsades de pointes - physiopathology (739) 739
long qt syndrome - physiopathology (677) 677
prolongation (674) 674
long-qt syndrome (643) 643
qt interval (597) 597
repolarization (547) 547
arrhythmias (534) 534
electrocardiography - drug effects (515) 515
drugs (501) 501
heart (484) 484
cardiac arrhythmia (483) 483
torsades de pointes - diagnosis (464) 464
dose-response relationship, drug (461) 461
torsades de pointes - etiology (431) 431
arrhythmias, cardiac - chemically induced (417) 417
qt prolongation (415) 415
electrophysiology (412) 412
early afterdepolarizations (409) 409
action potentials - drug effects (405) 405
dogs (405) 405
risk (399) 399
long qt syndrome - diagnosis (398) 398
electrocardiogram (396) 396
anti-arrhythmia agents - adverse effects (393) 393
medicine, general & internal (389) 389
interval (380) 380
sudden cardiac death (374) 374
analysis (363) 363
arrhythmias, cardiac - physiopathology (343) 343
cardiovascular (336) 336
heart rate - drug effects (336) 336
long qt syndrome - genetics (328) 328
adolescent (317) 317
anti-arrhythmia agents - therapeutic use (315) 315
herg (312) 312
anti-arrhythmia agents - pharmacology (306) 306
drug interactions (305) 305
rabbits (305) 305
toxicology (302) 302
heart conduction system - physiopathology (290) 290
aged, 80 and over (288) 288
interval prolongation (287) 287
antipsychotic agents - adverse effects (286) 286
tachycardia (278) 278
action potentials (268) 268
medicine & public health (264) 264
potassium channel (262) 262
cardiology (261) 261
drug therapy (258) 258
erg1 potassium channel (257) 257
de-pointes (255) 255
time factors (254) 254
risk assessment (251) 251
peripheral vascular disease (249) 249
therapy (247) 247
disease models, animal (242) 242
qt interval prolongation (241) 241
psychiatry (236) 236
ventricular tachycardia (234) 234
heart conduction system - drug effects (232) 232
cardiovascular system (227) 227
long qt syndrome - complications (227) 227
heart - drug effects (226) 226
mutation (225) 225
heart rate (223) 223
research (223) 223
proarrhythmia (218) 218
article (216) 216
cardiovascular diseases (214) 214
atrial fibrillation (212) 212
drug-related side effects and adverse reactions (212) 212
treatment outcome (212) 212
ventricular repolarization (210) 210
retrospective studies (209) 209
safety (205) 205
amiodarone (204) 204
potassium channels (204) 204
child (203) 203
pharmacology (200) 200
ventricular-tachycardia (200) 200
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5953) 5953
German (150) 150
French (136) 136
Japanese (119) 119
Spanish (66) 66
Polish (34) 34
Italian (22) 22
Chinese (18) 18
Russian (17) 17
Korean (15) 15
Portuguese (14) 14
Danish (10) 10
Hungarian (10) 10
Norwegian (7) 7
Swedish (6) 6
Dutch (5) 5
Finnish (4) 4
Czech (3) 3
Hebrew (3) 3
Turkish (3) 3
Belarusian (2) 2
Lithuanian (2) 2
Romanian (2) 2
Croatian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


12/2010
Torsades de pointes (TdP) or polymorphic ventricular tachycardia owing to drug-induced QT prolongation is a common cause of withdrawal of marketed drugs and... 
torsades de pointes | QT prolongation | Carbimazole
Web Resource
by Mann, G and Gunja, N
CLINICAL TOXICOLOGY, ISSN 1556-3650, 06/2017, Volume 55, Issue 5, pp. 473 - 473
Conference Proceeding
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2019, Volume 105, Issue 2, pp. 466 - 475
The International Council on Harmonization (ICH) S7B and E14 regulatory guidelines are sensitive but not specific for predicting which drugs are... 
TORSADES-DE-POINTES | DISOPYRAMIDE | EARLY AFTERDEPOLARIZATIONS | DISPERSION | DRUGS | VALIDATION | PHARMACOLOGY & PHARMACY | REPOLARIZATION | Research
Journal Article
Journal of Critical Care, ISSN 0883-9441, 09/2019
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 2018, p. 107815521881574
Journal Article
Critical Care Medicine, ISSN 0090-3493, 01/2013, Volume 41, Issue 1, pp. 263 - 306
Journal Article
Current Drug Safety, ISSN 1574-8863, 01/2010, Volume 5, Issue 1, pp. 97 - 104
Psychotropics are among the most common causes of drug induced acquired long QT syndrome. Blockage of Human ether-ago- go-related gene (HERG) potassium channel... 
Antipsychotics | Psychotropics | Antidepressants | Torsades de pointes | QTc prolongation
Journal Article
CLINICAL TOXICOLOGY, ISSN 1556-3650, 10/2019, Volume 57, Issue 10, pp. 936 - 937
Conference Proceeding
Journal of Medicinal Chemistry, ISSN 0022-2623, 08/2018, Volume 61, Issue 16, pp. 7234 - 7244
Novel 7-[(3aS,7aS)-3a-aminohexahydropyrano[3,4-c]pyrrol-2(3H)-yl]-6-fluoro-1-[(1R,2S)-2- fluorocyclopropyl]-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic... 
TORSADES-DE-POINTES | INFECTIONS | CHEMISTRY, MEDICINAL | INHIBITION | DRUG DISCOVERY | FLUOROQUINOLONES | QUINOLONES | PROLONGATION | RISK-ASSESSMENT | DERIVATIVES | LIPOPHILICITY
Journal Article
TOXICOLOGICAL SCIENCES, ISSN 1096-6080, 08/2013, Volume 134, Issue 2, pp. 412 - 426
Journal Article
Journal of Pharmacological and Toxicological Methods, ISSN 1056-8719, 07/2009, Volume 60, Issue 1, pp. 1 - 10
The problem of drug-induced hERG channel blockade, which can lead to acquired long QT syndrome and potentially fatal arrhythmias, has exercised drug developers... 
Kv7.1 | Ligand binding | hERG | HMR1556 | KCNQ1 | Torsades de pointes
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 10/2016, Volume 100, Issue 4, pp. 371 - 379
The ventricular arrhythmia Torsades de Pointes (TdP) is a common form of drug‐induced cardiotoxicity, but prediction of this arrhythmia remains an unresolved... 
Algorithms | Machine Learning | Humans | Risk Factors | Torsades de Pointes - chemically induced | Usage | Arrhythmia | Drug therapy | Torsade de pointes | Machine learning | Index Medicus | Abridged Index Medicus
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 02/2019, Volume 179, Issue 2, pp. 249 - 251
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 03/2004, Volume 350, Issue 10, pp. 1013 - 1022
  The single most common cause of the withdrawal or restriction of the use of marketed drugs has been QT-interval prolongation associated with polymorphic... 
ANTIARRHYTHMIC DRUGS | MEDICINE, GENERAL & INTERNAL | TORSADES-DE-POINTES | TRIGGERED ACTIVITY | CARDIAC-ARRHYTHMIA | M-CELLS | CLINICAL-FEATURES | VENTRICULAR ARRHYTHMIAS | ACUTE PROMYELOCYTIC LEUKEMIA | POTASSIUM CHANNEL | ATRIAL-FIBRILLATION | Side effects | Drug therapy | Health risk assessment | Toxicity | Decision making
Journal Article